Hinge Health, Inc. (HNGE)

Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	480.79	390.4	292.73
Revenue Growth (YoY)	-	33.37%	-
Cost of Revenue	106.58	89.81	98.55
Gross Profit	374.21	300.59	194.18
Selling, General & Admin	564.55	227.54	214.64
Research & Development	337.97	97.49	110.06
Operating Expenses	923	325.02	324.69
Operating Income	-548.79	-24.43	-130.51
Interest & Investment Income	20.57	20.57	21.7
Other Non Operating Income (Expenses)	-0.33	0.08	0.27
EBT Excluding Unusual Items	-528.55	-3.78	-108.55
Merger & Restructuring Charges	-1.68	-7.48	-
Pretax Income	-426.05	-11.26	-108.55
Income Tax Expense	0.83	0.68	-0.41
Net Income	-426.88	-11.93	-108.14
Net Income to Common	-426.88	-11.93	-108.14
Shares Outstanding (Basic)	22	14	13
Shares Outstanding (Diluted)	22	14	13
Shares Change (YoY)	-	4.16%	-
EPS (Basic)	-19.47	-0.88	-8.31
EPS (Diluted)	-19.47	-0.88	-8.31
Free Cash Flow	91.17	47.96	-65.89
Free Cash Flow Per Share	4.16	3.54	-5.06
Gross Margin	77.83%	77.00%	66.33%
Operating Margin	-114.14%	-6.26%	-44.59%
Profit Margin	-88.79%	-3.06%	-36.94%
Free Cash Flow Margin	18.96%	12.29%	-22.51%
EBITDA	-546.96	-22.08	-128.39
EBITDA Margin	-113.76%	-5.66%	-43.86%
D&A For EBITDA	1.83	2.35	2.13
EBIT	-548.79	-24.43	-130.51
EBIT Margin	-114.14%	-6.26%	-44.59%
Advertising Expenses	-	37.3	23.8

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q